Development of GD2-Specific Immunoliposomes for Immunotherapy of Neuroblastoma

被引：1
|
作者：
Huang, Wei [1 ]
Liu, Daofeng [1 ]
Guo, Linjie [1 ]
Marinova, Ekaterina [1 ]
Heczey, Andras [1 ]
Metelitsa, Leonid [1 ]
机构：
[1] Baylor Coll Medcine, Houston, TX USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33205-1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
396
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [21] Disialoganglioside GD2 directed immunotherapy of neuroblastoma
    Lode, H.
    Siebert, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S75 - S75
  • [22] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Yu, Lihua
    Huang, Lulu
    Lin, Danna
    Lai, Xiaorong
    Wu, Li
    Liao, Xu
    Liu, Jiale
    Zeng, Yinghua
    Liang, Lichan
    Zhang, Guanmei
    Wang, Bin
    Wu, Zhu
    Tao, Shaohua
    Liu, Yuchen
    Jiao, Cheng
    Chang, Lung-Ji
    Yang, Lihua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2643 - 2652
  • [23] Eradication of neuroblastoma by T-cells redirected with an optimized GD2-specific chimeric antigen receptor and IL-15
    Chen, Yuhui
    Sun, Chuang
    Metelitsa, Leonid
    Dotti, Gianpietro
    Savoldo, Barbara
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [24] Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies
    I. I. Doronin
    I. V. Kholodenko
    A. A. Zubareva
    K. N. Yarygin
    S. M. Deev
    R. V. Kholodenko
    Bulletin of Experimental Biology and Medicine, 2019, 166 : 541 - 547
  • [25] GD2-specific chimeric antigen receptor T cells targeting retinoblastoma
    Sujjitjoon, Jatuporn
    Atchaneeyasakul, La-ong Sri
    Tsao, Shih-Ting
    Sayour, Elias
    Yenchitsomanus, Pa-thai
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [26] GD2-specific CAR T cell therapies for pediatric solid cancers
    Rossig, Claudia
    CANCER RESEARCH, 2024, 84 (17)
  • [27] Tumor-Associated Macrophages Via Up-Regulation of PD1 Ligands Protect Neuroblastoma from Immunotherapy With NKT Cells Expressing GD2-Specific Chimeric Antigen Receptor
    Liu, Daofeng
    Courtney, Amy N.
    Heczey, Andras
    Marinova, Ekaterina
    Tian, Gengwen
    Guo, Linjie
    Gao, Xiuhua
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    MOLECULAR THERAPY, 2015, 23 : S205 - S205
  • [28] Targeting of Ewing sarcoma by CAR-reengineered GD2-specific T cells
    Kailayangiri, Sareetha
    Altvater, Bianca
    Meltzer, Jutta
    Leuchte, Katharina
    Hotfilder, Marc
    Juergens, Heribert
    Rossig, Claudia
    CANCER RESEARCH, 2011, 71
  • [29] Prolonged ILEUS Secondary to Anti-Gd2 Immunotherapy for Neuroblastoma
    Osuna Marco, M.
    Alcaide Alvarez, C.
    Barrio Merino, A.
    Cilla, C.
    Bengoechea, C.
    Lancharro, A.
    Villa Alcazar, M.
    Lopez-Ibor, B.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S524 - S524
  • [30] The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells
    Kowalczyk, Aleksandra
    Gil, Malgorzata
    Horwacik, Irena
    Odrowaz, Zaneta
    Kozbor, Danuta
    Rokita, Hanna
    CANCER LETTERS, 2009, 281 (02) : 171 - 182
12345